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Abstract
Although classical protein tyrosine phosphatase (PTP) superfamily members are cysteine-dependent,
emerging evidence shows that many acid phosphatases (AcPs) function as histidine-dependent PTPs
in vivo. These AcPs dephosphorylate phospho-tyrosine substrates intracellularly and could have roles
in development and disease. In contrast to cysteine-dependent PTPs, they utilize histidine, rather
than cysteine, for substrate dephosphorylation. Structural analyses reveal that active site histidine,
but not cysteine, faces towards the substrate and functions as the phosphate acceptor. Nonetheless,
during dephosphorylation, both histidine-dependent and cysteine-dependent PTPs use their active
site arginine and aspartate for substrate binding and proton donation, respectively. Thus, we propose
that they should be referred to as a distinct group of ‘histidine-dependent PTPs’ within the PTP
superfamily.
Protein tyrosine phosphatase superfamily
Cellular protein tyrosine phosphorylation is regulated by a dynamic equilibrium between the
activity of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). Most
PTP superfamily members are structurally conserved and depend on the cysteine residue in
their active site for phosphotyrosine (pTyr) dephosphorylation [1]. These phosphatases are
broadly categorized into classical PTPs, including the receptor and the non-receptor PTPs, the
dual-specificity phosphatases (DSPs), cell division cycle 25 (cdc25) phosphatases and the low
molecular weight (LMW) PTPs [2]. The classical PTPs, which regulate diverse cellular signals,
are marked by the presence of a conserved active site signature sequence, C(X)5RS/T (where
X is any amino acid) [1,2]. Structural comparisons between the classical PTPs and DSPs reveal
a conserved architecture in their active sites: a conserved active site cysteine residue that serves
as the phosphate group acceptor is crucial for their PTP activity, and a substitution in the
cysteine residue results in their inactivation [2–4]. Studies reveal that a distinct group of closely
related acid phosphatases (AcPs) are histidine-dependent, but cysteine-independent, PTPs that
dephosphorylate various intracellular pTyr protein substrates. Similar to the cysteine-
dependent PTPs, several reports indicate that these AcPs, which use histidine as their phosphate
acceptor, are expressed in specialized, differentiated cells and regulate a variety of cellular
processes, including proliferation and differentiation. Based on their intracellular PTP activity,
Corresponding author: Lin, M.-F. (mlin@unmc.edu).
NIH Public Access
Author Manuscript
Trends Biochem Sci. Author manuscript; available in PMC 2009 November 10.
Published in final edited form as:

















































we propose that these histidine-dependent AcPs should be designated as histidine-dependent
PTPs and as a distinct group within the PTP superfamily.
Histidine-dependent AcPs: in vivo PTPs
A closer look at the AcPs that exhibit PTP activity shows that they are expressed in diverse
organisms (Figure 1). Such histidine-dependent AcPs from plants, for example Lens
esculenta (lentils) and Solanum tuberosom (potato tuber) [5,6], prokaryotes, for example
Escherichia coli, Staphylococcus aureus and Streptomyces coelicolor [7–10], lower
eukaryotes, for example Entamoeba histolytica [11], and specialized cells in higher eukaryotes
[12–19] exhibit both AcP and PTP activity. Amino acid sequence analyses reveal that histidine-
dependent AcPs have a conserved amino acid sequence motif, RHGXRXP (where X is any
amino acid), within their active domain [20]. The conservation of the PTP activity of histidine-
dependent AcPs from bacteria to humans suggests the preservation of a specialized function
of these members.
It should be noted that the nomenclature of these phosphatases as ‘AcPs’ is essentially based
on the in vitro biochemical measurement of their optimal phosphatase activity at an acidic pH
over small organic compounds containing phosphates, such as paranitrophenyl phosphate
(pNPP). It is noteworthy that most of the classical cysteine-dependent PTPs, including PTP1A
and PTP1B, also hydrolyze pNPP in vitro with acidic pH optima [21]. Similarly, Wzb, an E.
coli histidine-dependent phosphatase containing the AcP signature sequence,
dephosphorylates pTyr residues of the Wzc kinase in vivo, whereas it biochemically hydrolyzes
pNPP at an acidic pH of 6.5 [8]. Thus, the nomenclature of these phosphatases, which exhibit
PTP activity in vivo, as AcPs based on their biochemical activity at acidic pH towards
anomalous artificial substrates, such as pNPP, is misleading [22,23]. Indeed, like the cysteine-
dependent PTPs, histidine-dependent phosphatases can dephosphorylate pTyr proteins
optimally under a neutral pH, that is, at a pH level similar to intracellular pH [17,19,22]. Thus,
we propose that these phosphatases should be renamed as PTPs based on their in vivo activity
towards intracellular pTyr substrates. Previous suggestions to rename cellular prostatic AcP
(cPAcP) as prostate-specific PTP and the LMW AcPs as LMW PTPs were based, in part, on
their PTP activity at neutral pH [22,24]. Recent studies have characterized PTP-dependent
roles for these histidine-dependent AcPs within key cellular signaling processes in various
differentiated cells [8,19,25–28]. Thus, the in vivo role of histidine-dependent phosphatases in
the dephosphorylation of pTyr proteins indicates that they represent a distinct group of PTPs
under the PTP superfamily.
Structural features of histidine-dependent versus cysteine-dependent PTPs
Structural analyses of classical PTPs, such as PTP1B and CD45 (cluster of differentiation 45
phosphatase), reveal that these PTPs have deep active sites (9 Å deep), making them ‘reachable’
only by longer residues, for example tyrosine, but not shorter serine or threonine residues. By
contrast, DSPs, such as human vaccinia h1-related phosphatases (VHRs) and phosphatase and
tensin homolog phosphatases (PTENs), have active sites shallow enough (ᙺ6–8 Å) to be
‘reached’ by shorter serine or threonine residues or phospholipids (Figure 2a) [29]. Human
PAcP and E. coli AcP subunits exhibit large, open active site conformations similar to the DSPs
(Figure 2a) [30–33].
Histidine-dependent PTPs, for example PAcP and ACPT (testicular AcP), contain the
conserved histidine, arginine and aspartic acid residues in their active sites. The analysis of
phospho-enzyme intermediates revealed that PAcP His12 functions as the phosphate acceptor
for its AcP and PTP activities; Asp258 apparently serves as the proton donor for the substrate-
leaving group [34]. Further analyses using chemical modification, site-directed mutagenesis
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and X-ray crystallographic approaches have confirmed the importance of His12 and Asp258
in PAcP AcP and PTP activity [30–32,34,35]. The sequence homology among the AcPs
exhibiting PTP activity in their active sites suggests that the histidine corresponding to the
His12 of PAcP is a crucial residue for their PTP activity.
A closer examination of histidine-dependent phosphatase crystal structures indicates that the
nucleophilic His12 residue is located spatially closer to the substrate, whereas active site
cysteine residues face away from the substrate (Figure 2). A comparison of the PAcP active
site bound to a phosphate ion with that of the PAcP holoenzyme reveals the outward movement
of Cys183 from phosphate (Figure 2a and Figure 2b). Similarly, in E. coli AcP, substrate
binding causes His150 to move closer to the substrate, which forms the hydrogen bonds with
the substrate when the substrate forms covalent bonds with His189 [33]. The nucleophilic
cysteine in cysteine-dependent phosphatases, for example PTP-1B, VHR and PTEN, is
spatially closer to the substrate than the histidine residues are to the substrate during the
dephosphorylation reaction, even though the active site histidine residue is located next to the
cysteine residue in these cysteine-dependent PTPs (Figure 2a). Further studies are needed to
understand the requirement of differential utilization of cysteine and histidine in pTyr
dephosphorylation.
Interestingly, the cysteine residues in the active sites of histidine-dependent PTPs,
corresponding to Cys183 and Cys281 of PAcP, are not essential for their PTP activity [35].
Although these residues are conserved in many eukaryotes, they are not conserved in lower
prokaryotes, implying that these cysteinyl residues might be used to dephosphorylate substrates
other than pTyr proteins in higher eukaryotes. For example, in vitro biochemical studies
indicate that human PAcP hydrolyzes lysophosphatidic acid and phosphatidyl inositol 3
phosphate (PI3P) and thus could function as a phospholipid phosphatase, similar to PTEN
[36,37]. However, the potential involvement and biological relevance of the active cysteine in
this context requires further validation.
Based on the available data for cPAcP, a model for the histidine-dependent PTP-mediated
dephosphorylation reaction can be generated (Figure 3). cPAcP binds its substrate
noncovalently using side chains of three arginine residues (Arg11, Arg15 and Arg79) [31,
34]. The His12 imidazole ring provides a pair of electrons for nucleophilic attack to the
phosphate group. This utilization of histidine by histidine-dependent PTPs parallels the use of
cysteine for nucleophilic attack of phosphate groups by cysteine-dependent PTPs. The function
of Asp258 in dephosphorylation is apparently conserved between histidine-dependent and
cysteine-dependent PTP activity. Cooperatively, Asp258 donates a proton from its carboxyl
group to the substrate resulting in the formation of the phosphoenzyme intermediate and the
liberation of dephosphorylated substrate. Additionally, Asp258 might also stabilize the
phospho-His12 intermediate. Subsequently, nucleophilic attack of the phosphoenzyme
intermediate occurs through a water molecule to release the phosphate group and to return a
proton to the Asp258 carboxyl group [31,34]. Based on X-ray crystallographic studies, Asp258
is proposed to polarize the water molecule to facilitate the nucleophilic attack of water on the
phospho-histidine intermediate [32]. Alternatively, solvent isotope studies indicate that
Asp258 functions in positioning the water molecule during the dephosphorylation reaction
[31]. Further studies will be required to address the biochemical role of this aspartic acid in
histidine-dependent PTPs.
Studies of cPAcP histidine-dependent PTP activity have been paralleled by research on other
AcPs that are expressed in a variety of tissues. For example, ACPT, which is expressed in
human testicular tissue and brain cells, shows 60% amino acid identity to PAcP and exhibits
PTP activity at physiological pH [18,19]. Importantly, the crucial histidine (His12) and the
aspartate (Asp259) residues in the ACPT active site, which are homologous to PAcP His12
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and Asp258, are conserved [19]. Other AcPs with a conserved active site histidine residue,
corresponding to His12 of PAcP, that either exhibit demonstrable PTP activity or are sensitive
to PTP inhibitors, for example orthovanadate, include those expressed in E. coli, yeast
(Schizosaccharomyces pombe), Caenorhabditis elegans and in human lysosomes [7,38–40].
Although detailed kinetic mechanisms are not yet available, we propose that these histidine-
dependent phosphatases represent a discrete group of PTPs, distinct from the ubiquitously
expressed classical cysteine-dependent PTPs.
Although cysteine-dependent PTPs and histidine-dependent PTPs share common modes of
regulation, for example reversible inactivation by oxidation of cysteine or histidine residues
in respective PTPs by physiological reactive oxygen species (ROS) levels, differences in
activation exist. In particular, subunit dimerization might significantly enhance the specific
activity of the histidine-dependent phosphatases in a similar manner to the action of
dimerization on the receptor tyrosine kinases, such as the epidermal growth factor receptor
(EGFR) family [41–43]. Indeed, Trp106 and His112 residues of mature rat PAcP, which are
thought to regulate its dimerization and subsequent activation [44], are conserved in AcPs, for
example ACPT, C. elegans AcP and human lysosomal AcPs, thus indicating that they might
also be activated by dimerization [19]. By contrast, dimerization of classical receptor PTPs,
such as receptor protein tyrosine phosphatase Į (RPTPĮ), leucocyte antigen-related
phosphatase (LAR) and CD45, results in their inactivation [45]. Thus, the use of subunit
dimerization could differentiate the regulation of histidine-dependent PTP activity from the
regulation of cysteine-dependent PTP activity. Future studies will be necessary to determine
the role of dimerization in regulating PTP activity of other AcPs.
Intracellular substrates of histidine-dependent PTPs
Evidence that has accumulated over the past decade has shed light on the biological relevance
of histidine-dependent PTPs. In terms of their substrates and in regulating key cellular signaling
events, these PTPs function in a manner similar to cysteine-dependent PTPs. Here, we discuss
the biological functions of representative histidine-dependent PTPs and their respective in
vivo substrates.
ErbB-2: a cPAcP substrate in prostate epithelia
In differentiated prostate epithelial cells, PAcP is expressed in two forms – a secreted form,
the physiological functions of which remain unidentified, and an intracellular form, which is
the focus of this discussion. cPAcP, the intracellular form, regulates growth in prostate
epithelial cells. For example, differentiated prostate epithelial cells express high cPAcP levels
and exhibit slow cell proliferation, whereas in prostate carcinomas, cPAcP expression is
diminished and cell proliferation is increased [25]. Biochemical and in vivo studies indicate
that ErbB-2 (erythroblastosis virus oncogene, also called Her-2 or Neu), an EGFR family
member and a transmembrane receptor kinase, is an in vivo cPAcP substrate [26,28,46,47].
Ectopic cPAcP expression in aggressive prostate cancer cells promotes decreased ErbB-2
tyrosine phosphorylation that results in decreased growth rates and tumorigenicity [25–28,
47,48]. Importantly, intratumoral injection of ACPP cDNA, but not a mutant version that lacks
PTP activity, into xenograft tumors leads to tumor regression, at least in part via
downregulating ErbB-2 phosphorylation [28]. Conversely, small interfering RNA (siRNA) or
antisense-mediated PAcP knockdown in the LNCaP human prostate adenocarcinoma cell line
results in increased ErbB-2 tyrosine phosphorylation and subsequent cell growth [47].
Importantly, knockout animal studies validate cPAcP as a tumor suppressor because prostate
adenocarcinomas spontaneously develop in male mice that lack exon 3 in the PAcP gene
(Acppǻ3/ǻ3) [37]. Thus, cPAcP is a histidine-dependent PTP that regulates prostate epithelial
cell growth, at least in part, through ErbB-2 dephosphorylation.
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ErbB-4: an ACPT substrate in neuronal cells
ACPT, originally identified in testicular epithelial cells, is also highly expressed in neuronal
tissues and exhibits more than 60% amino acid identity with PAcP. In differentiated neuronal
cells, ACPT colocalizes and directly interacts with ErbB-4, an EGFR family member that
regulates neuronal differentiation [19]. Importantly, ACPT dephosphorylates ErbB-4 in the
synaptic sites of differentiated neuronal cells, which indicates that ACPT might have a crucial
role in neuronal differentiation [19]. In fact, ACPT expression inhibits ErbB-4-mediated
neuregulin (NRG)-induced neurite outgrowth in pheochromocytoma (PC)-12 cells, a
differentiation phenotype [19]. Thus, the interaction between ACPT and ErbB-4 could
participate in neuronal development and differentiation. Further studies are needed to identify
the key neuronal signaling pathways that are regulated by the ACPT–ErbB-4 interaction.
Histidine-dependent PTPs in plants
Phosphatases have been linked to several tyrosine phosphorylation signaling pathways in
plants, for example seed germination. In lentil seeds, histidine-dependent AcP PTP activity
increases at the onset of seed germination, thus indicating its possible involvement in seed
germination [5]. The expression of maize (Zea mays) AcP, which has high activity towards
pTyr substrates, also correlates with seed germination [49]. In particular, its protein levels
negatively correlate with the phosphorylation of a 14-kDa pTyr protein, a putative intracellular
substrate for this AcP [49]. Similarly, AcPs exhibiting significant phosphatase activity towards
pTyr substrates have also been reported in dormant hazel (Corylus avellana) seeds [50]. Further
studies will be required to elucidate the biological significance of these AcPs in plant signaling
pathways.
Wzc: a Wzb substrate in prokaryotes
Wzc, a transmembrane kinase, participates in the regulation of prokaryotic extracellular
polysaccharide synthesis, for example in E. coli and Lactobacillus rhamnosus, and is
dephosphorylated intracellularly by the Wzb phosphatase [8,51]. Wzb phosphatase activity is
histidine-dependent. Whereas specific serine-substituted cysteine mutants, for example C78S
and C6S, retain more than 60% of phosphatase activity, alanine-substituted histidine mutants,
for example H42A, H43A, H5A and H7A, result in the complete loss of phosphatase activity
towards pNPP [51]. Further studies will be needed to address the role of histidine in Wzc-
mediated Wzb dephosphorylation in vivo. Similarly, phosphatase 1 from psychrophilic
bacteria, for example Shewanella spp., exhibits histidine-dependent phosphatase activity
towards pTyr substrates [52]. Future studies should be directed at identifying other bacterial
AcPs that function as histidine-dependent PTPs, as well as the physiological substrates of these
AcPs.
Concluding remarks and future perspectives
Several lines of evidence support the notion that diverse histidine-dependent AcPs from various
species function as histidine-dependent PTPs, representing a distinct subgroup of the PTP
superfamily. Significantly, the active site histidine is conserved in a wide variety of organisms.
Interestingly, histidine-dependent PTPs share some common modes of regulation with
cysteine-dependent PTPs, such as ROS-mediated inactivation by reversible oxidation of
cysteine or histidine residues [53,54]. Nonetheless, their unique regulatory mechanism(s),
including dimerization, could differentiate histidine-dependent PTPs from classical cysteine-
dependent PTPs. Additional biochemical studies will be needed to elucidate this point.
Current studies are focused on analyzing the molecular events governed by histidine-dependent
PTPs. These phosphatases could function as regulators of specific biological events, for
example proliferation and differentiation in specialized cell types. Although they function as
Veeramani et al. Page 5

















































AcPs when small organic phospho-compounds are used as substrates, their physiological role
as neutral PTPs on cellular pTyr proteins suggests several possibilities. For example, the
differential pH optima could allow histidine-dependent phosphatases to interact with different
in vivo substrate molecules in different sub-cellular compartments. cPAcP might function both
as a PTP and a phospholipid phosphatase: it can dephosphorylate both pTyr and PI3P and
regulate ErbB-2-phosphatidylinositol 3-OH kinase signaling [26,27,35,37,47]. Future studies
should be directed at identifying additional AcPs that function as histidine-dependent PTPs in
vivo. These studies might provide answers regarding the evolutionary relationship of these
histidine-dependent phosphatases in comparison to the cysteine-dependent PTPs. In addition,
exploring the conditions under which the cells employ two different kinetic mechanisms for
dephosphorylation will help us to understand more about the evolutionary adaptation of
organisms. Development of novel inhibitors that react with the active site histidine should be
useful for mechanism-based studies and would help us to identify the biological relevance of
these histidine-dependent PTPs. Importantly, it is necessary to explore their clinical
significance in human diseases, for example cancer, and their potential role in therapy against
human disease.
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Relatedness of histidine-dependent acid phosphatases (AcPs) in prokaryotic and eukaryotic
cells. A phylogenetic tree based on the amino acid sequences of different prokaryotic and
eukaryotic AcPs that use active site histidine as their phosphate acceptor. The tree was
constructed using the Vector NTI program (Invitrogen, USA).
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Structural comparison of the active sites of classical cysteine-dependent and histidine-
dependent PTPs. The structures of the active sites of cysteine-dependent and histidine-
dependent PTPs are compared using Swiss-PDB viewer software. Key amino acids are labeled.
Color codes for amino acids: histidine – magenta; cysteine – green; arginine – red; structural
amino acids encompassing active site – yellow; substrate or inhibitors – dark blue. (a)
Comparison of X-ray crystallographic structures of both cysteine-dependent and histidine-
dependent PTPs with their substrates/inhibitors; these comparisons reveal striking differences
in their active site conformations. Classical cysteine-dependent PTPs, for example human
PTP-1B (i) and CD45 phosphatases (ii), possess a deep active site that can be reached by
tyrosine residues, which determines their substrate specificity. By contrast, both dual
specificity phosphatases, such as human VHR (iii) and PTEN (iv), and histidine-dependent
AcPs, for example E. coli AcP (v) and human cPAcP (vi), have relatively shallow active sites.
The dotted black line depicts the depth of the active site cleft of the PTPs. (b) In histidine-
dependent PTPs, here PAcP, the phosphate acceptor His12 is positioned towards phosphate
(i), vanadate (ii) and tartrate (iii). A comparison with Figure 2a indicates that in E. coli AcP,
another histidine-dependent PTP, histidine faces towards the substrate. By contrast, in cysteine-
dependent PTPs (Figure 2a, i–iv), the active site cysteine is positioned towards the substrate,
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whereas the histidine residue faces away from the substrate during a dephosphorylation
reaction.
Veeramani et al. Page 11


















































Schematic representation of substrate dephosphorylation by a histidine-dependent
phosphatase. The dephosphorylation reaction is summarized using cPAcP as a model histidine-
dependent PTP and tyrosine-phosphorylated ErbB-2 as the model substrate. cPAcP His12
serves as the phosphate acceptor in Step 1 of the reaction. Asp258 functions as the proton donor
(Steps 1 and 2). Alternatively, Asp258 might also stabilize the phospho-His12 intermediate
and position the water molecule to favor the nucleophilic attack on the phosphate (Step 2).
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